Rachelle E. Senzon is currently the Director of Clinical Development Operations at BioNTech SE, where Rachelle E. focuses on process excellence and oversight in Cell & Gene Therapy. Previously, Rachelle E. held positions at Celgene, Novartis Pharmaceuticals, Atlantic Health System, Rutgers Cancer Institute of New Jersey, The National Institutes of Health, and Yale New Haven Hospital in various clinical research and nursing roles. Rachelle holds a Bachelor of Science degree with a major in Nursing and a minor in Psychology from Syracuse University.
June, 2022 - present